MANUFACTURING
BIOTECH INNOVATION
Scroll
PLASMID
Plasmid DNA development and manufacturing for viral vector and mRNA production
ANEMOCYTE MEANS TALENTS
Here at Anemocyte, we support, value and inspire those with a vision of a different world.
NEWS & EVENTS
Anemocyte is heading to Boston!
We’re excited to announce our participation in the BIO International Convention 2025, taking place from June 16–19 at the Boston...
Anemocyte at AFI’s symposium in Rimini
We are thrilled to announce our participation in the 64th AFI Symposium, taking place from June 11 to 13, 2025,...
Anemocyte is thrilled to announce its participation in the upcoming international conference on gene therapy
Anemocyte, a biotech company at the forefront of advanced therapy development, is excited to join the upcoming international conference on...
Altheia Science and Anemocyte: A Strategic Alliance Accelerating the Future of Cell & Gene Therapies
Altheia Science proudly announces the success of its strategic collaboration with Anemocyte, a leading developer and manufacturer of pDNA and...
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell based therapies...
Anemocyte at TIDES USA 2025 – Oligonucleotide & Peptide Therapeutics
Anemocyte is excited to announce its participation as an attendee at TIDES USA 2025, taking place from May 19–22, 2025,...
MANUFACTURING
BIOTECH
INNOVATION
PLASMID
Plasmid DNA development and manufacturing for viral vector and mRNA production
ANEMOCYTE MEANS TALENTS
Here at Anemocyte, we support, value and inspire those with a vision of a different world.
NEWS & EVENTS
Anemocyte is heading to Boston!
We’re excited to announce our participation in the BIO International Convention 2025, taking place from June 16–19 at the Boston...
Anemocyte at AFI’s symposium in Rimini
We are thrilled to announce our participation in the 64th AFI Symposium, taking place from June 11 to 13, 2025,...
Anemocyte is thrilled to announce its participation in the upcoming international conference on gene therapy
Anemocyte, a biotech company at the forefront of advanced therapy development, is excited to join the upcoming international conference on...
Altheia Science and Anemocyte: A Strategic Alliance Accelerating the Future of Cell & Gene Therapies
Altheia Science proudly announces the success of its strategic collaboration with Anemocyte, a leading developer and manufacturer of pDNA and...
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell based therapies...
Anemocyte at TIDES USA 2025 – Oligonucleotide & Peptide Therapeutics
Anemocyte is excited to announce its participation as an attendee at TIDES USA 2025, taking place from May 19–22, 2025,...
